If this is your first visit, be sure to check out the FAQ by clicking the link above. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. |
|
|
Thread Tools | Display Modes |
#1
|
|||
|
|||
The REAL Reason For the Growth of ADHD in the US
http://www.genengnews.com/news/bnite..._TO_NEWSML.xml
Breaking News Excerpts: The Current Marketed Psycho Stimulants Quickly and Effectively Alleviate ADHD Symptoms Business Implications -- Currently, the most common pharmacological treatments for adult ADHD are psychostimulants. The exact mechanisms by which these agents improve symptoms are not well understood, but their use is substantial and effective: physicians interviewed state that 80-90% of their patients treated with either methylphenidate or amphetamine experience a reduction in ADHD symptoms. -- Because psychostimulants are efficacious, there is little demand for novel mechanisms to treat adult ADHD. Shire's NRP-104, a pro-drug of amphetamine, is the most exciting drug in development for ADHD, and we expect it to achieve blockbuster status. This drug, expected to launch in 2010, will offer the efficacy of amphetamine without the potential for abuse. Overall, Shire will launch four new ADHD agents by 2010, establishing itself as the market leader. -- Growth in the ADHD market will be fuelled by several favourable factors, including physician adoption of a broader definition of the disease, a low rate of misdiagnosis compared with other psychiatric disorders, and an increase in the number of adults who self-refer themselves for treatment. In addition, a growing selection of drugs approved for treatment of adult ADHD, a higher rate of compliance, and an increase in the number of days treated will drive growth in this therapeutic market. Contents Include: -- Introduction -- Overview of Adult ADHD -- Prevalence of Adult ADHD -- Targets for ADHD Drug Development -- Current Therapies for ADHD -- Promising Emerging Therapies -- Factors Driving and Restricting Growth in the Adult ADHD Market -- Outlook for the Adult ADHD Market -- Appendix Companies Mentioned: -- Alza -- Boehringer Ingelheim -- Cephalon -- Eli Lilly -- GlaxoSmithKline -- Novartis -- Shire -- UCB's Metadate CD -- Wyeth |
Thread Tools | |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
Ped Med: ADHD Treatments Raise Questions | Jan Drew | Kids Health | 6 | March 29th 06 11:38 PM |
Ritalin and Liver cancer | Tim Campbell | General | 561 | June 17th 05 02:48 PM |
Ritalin and Liver cancer | Tim Campbell | Kids Health | 563 | June 17th 05 02:48 PM |
A Few Simple Truths About ADHD and Stimulant Drugs | Psi | Kids Health | 28 | April 23rd 04 02:40 PM |
Letter to APA 5/03 dubunking BS ADHD | SickofCrazyBS | Kids Health | 0 | November 25th 03 05:48 AM |